[go: up one dir, main page]

PL2238458T3 - Sposób przewidywania odpowiedzi na terapię farmaceutyczną otyłości - Google Patents

Sposób przewidywania odpowiedzi na terapię farmaceutyczną otyłości

Info

Publication number
PL2238458T3
PL2238458T3 PL08867898T PL08867898T PL2238458T3 PL 2238458 T3 PL2238458 T3 PL 2238458T3 PL 08867898 T PL08867898 T PL 08867898T PL 08867898 T PL08867898 T PL 08867898T PL 2238458 T3 PL2238458 T3 PL 2238458T3
Authority
PL
Poland
Prior art keywords
obesity
pharmaceutical agent
predicting responsiveness
pharmaceutical therapy
biomarker
Prior art date
Application number
PL08867898T
Other languages
English (en)
Inventor
Jennifer K Leohr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40386209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2238458(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL2238458T3 publication Critical patent/PL2238458T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08867898T 2007-12-19 2008-12-18 Sposób przewidywania odpowiedzi na terapię farmaceutyczną otyłości PL2238458T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1488107P 2007-12-19 2007-12-19
PCT/US2008/087367 WO2009085917A1 (en) 2007-12-19 2008-12-18 Method for predicting responsiveness to a pharmaceutical therapy for obesity
EP08867898A EP2238458B1 (en) 2007-12-19 2008-12-18 Method for predicting responsiveness to a pharmaceutical therapy for obesity

Publications (1)

Publication Number Publication Date
PL2238458T3 true PL2238458T3 (pl) 2012-03-30

Family

ID=40386209

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08867898T PL2238458T3 (pl) 2007-12-19 2008-12-18 Sposób przewidywania odpowiedzi na terapię farmaceutyczną otyłości

Country Status (17)

Country Link
US (2) US8355877B2 (pl)
EP (2) EP2235544A1 (pl)
JP (1) JP5242701B2 (pl)
KR (2) KR20100088624A (pl)
AT (1) ATE530916T1 (pl)
AU (2) AU2008343177B2 (pl)
BR (2) BRPI0821051B1 (pl)
CA (2) CA2710248A1 (pl)
CY (1) CY1112352T1 (pl)
DK (1) DK2238458T3 (pl)
ES (1) ES2373625T3 (pl)
HR (1) HRP20110840T1 (pl)
MX (1) MX2010006890A (pl)
PL (1) PL2238458T3 (pl)
PT (1) PT2238458E (pl)
SI (1) SI2238458T1 (pl)
WO (2) WO2009085917A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012001271A2 (pt) * 2009-07-22 2016-02-10 Lilly Co Eli método para a previsão de ganho de peso associado com uma terapia farmacêutica
US20160131603A1 (en) * 2013-06-18 2016-05-12 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Methods of predicting of chemical properties from spectroscopic data
WO2016065463A1 (en) * 2014-10-28 2016-05-06 2352409 Ontario Inc. Methods for providing personalized diet and activity recommendations that adapt to the metabolism of each dieter individually using frequent measurements of activity and triglyceride levels
KR102397234B1 (ko) 2020-09-17 2022-05-12 가천대학교 산학협력산 약물 순응도 평가 방법 및 시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2384292A (en) 1991-07-30 1993-03-02 North Carolina State University Method and apparatus for measuring blood lipoprotein levels by nmr spectroscopy
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
WO2000051054A1 (en) * 1999-02-26 2000-08-31 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
US6617167B2 (en) 2001-08-01 2003-09-09 Liposcience, Inc. Method of determining presence and concentration of lipoprotein X in blood plasma and serum
WO2003075742A2 (en) * 2002-03-05 2003-09-18 Merck & Co., Inc. Biomarker for efficacy of appetite suppressant drugs
JP5248854B2 (ja) * 2004-04-01 2013-07-31 リポサイエンス，インコーポレイテッド 臨床ｎｍｒ体外診断解析器の作動方法及び臨床ｎｍｒ体外診断解析器
WO2006098394A1 (ja) * 2005-03-14 2006-09-21 Japan Tobacco Inc. 脂質吸収抑制方法および脂質吸収抑制剤
EP1876448A1 (en) * 2005-09-30 2008-01-09 DIGILAB BioVisioN GmbH Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones.

Also Published As

Publication number Publication date
EP2235544A1 (en) 2010-10-06
JP2011508218A (ja) 2011-03-10
JP5242701B2 (ja) 2013-07-24
AU2008343187A1 (en) 2009-07-09
WO2009085927A1 (en) 2009-07-09
AU2008343177B2 (en) 2013-09-26
CA2710395A1 (en) 2009-07-09
KR20100084577A (ko) 2010-07-26
US8355877B2 (en) 2013-01-15
BRPI0821364A2 (pt) 2015-06-16
BRPI0821051B1 (pt) 2022-02-08
ATE530916T1 (de) 2011-11-15
US20100268474A1 (en) 2010-10-21
EP2238458A1 (en) 2010-10-13
PT2238458E (pt) 2012-01-11
CA2710248A1 (en) 2009-07-09
US8084261B2 (en) 2011-12-27
EP2238458B1 (en) 2011-10-26
ES2373625T3 (es) 2012-02-07
AU2008343177A1 (en) 2009-07-09
HRP20110840T1 (hr) 2011-12-31
CY1112352T1 (el) 2015-12-09
WO2009085917A1 (en) 2009-07-09
BRPI0821051A2 (pt) 2015-06-16
KR20100088624A (ko) 2010-08-09
DK2238458T3 (da) 2012-01-23
US20100248375A1 (en) 2010-09-30
CA2710395C (en) 2016-10-18
MX2010006890A (es) 2010-09-30
KR101240875B1 (ko) 2013-03-08
SI2238458T1 (sl) 2012-02-29

Similar Documents

Publication Publication Date Title
WO2012078806A3 (en) Non-gaming on-line achievement awards
EP2219130A4 (en) METHOD AND APPARATUS FOR DETECTING THE MALICIOUS BEHAVIOR OF A COMPUTER PROGRAM
EP2587473A4 (en) ACTIVE MATRIX SUBSTRATE, DISPLAY DEVICE AND METHOD FOR TESTING THE ACTIVE MATRIX SUBSTRATE OR DISPLAY DEVICE
EP2253268A4 (en) DEVICE AND METHOD FOR MEASURING THE RESISTANCE AND METHOD FOR DISPLAYING THE RESISTANCE TO THE RESISTANCE
WO2008135986A3 (en) System, method and device for comprehensive individualized genetic information or genetic counseling
MY164394A (en) Device and method for determining information related to a medical device
FR2929325B1 (fr) Dispositif et procede d'equilibrage de pression dans une enceinte palier de turboreacteur
NZ602497A (en) Enterobacter sp. 638 and methods of use thereof
WO2012058609A3 (en) Method and apparatus for selecting a tracking method to use in image guided treatment
EP2357562A4 (en) SYSTEM FOR ASSESSING ACTIONS IN RESPECT OF EVENTS DETECTED, METHOD FOR ASSISTING THE EXECUTION OF ACTIONS IN REACTION TO DETECTED EVENTS, AID DEVICE AND COMPUTER PROGRAM
EP2354948A4 (en) DEVICE FOR SUPPORTING THE DETECTION OF A DEFECT EVENT, METHOD FOR SUPPORTING THE DETECTION OF A DEFECT EVENT, AND COMPUTER PROGRAM
IL208723A0 (en) Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
TWI366135B (en) Method for restoring bios and computer thereof
BRPI0917616A2 (pt) arranjo para medir a velocidade local de um líquido que contém um material magnético em uma veia dentro de uma região de ação, método para medir a velocidade local de um líquido que contém um material magnético em uma veia dentro de uma região de ação e programa de computador
EP2513336A4 (en) METHOD FOR CHARACTERIZING THE IMMUNE FUNCTION OF EX VIVO INDUCTIVE HOST OF OFFENSIVE AND DEFENSIVE IMMUNE MARKERS
MX2014000322A (es) Tecnologia de simulacion integrada.
PL2238458T3 (pl) Sposób przewidywania odpowiedzi na terapię farmaceutyczną otyłości
PL1794729T3 (pl) Sposób, urządzenie i produkt programu komputerowego do aktywowania prawa do użycia co najmniej jednej pozycji zabezpieczonej treści
WO2009063226A3 (en) Methods relating to breathing disorders
EP2109824A4 (en) PERIPHERAL COMPUTER DEVICE IMPLEMENTED AS OPTICAL STORAGE DEVICE AND / OR SOFTWARE DEPOSITED DISK AND METHOD FOR IMPLEMENTING SAME
IN2013CN00326A (pl)
GB201108692D0 (en) A method, apparatus and computer program product for determining the strain induced at a selected point in a stiffened panel structure in response to a load
EP2658467A4 (en) CATHETER SHELL, PACKAGING SYSTEM, INSTRUCTION USE AND CORRESPONDING METHODS
GB0613698D0 (en) Method and apparatus for measuring activity in the peripheral nervous system
ZA200904898B (en) Advertising method and system with use of multi-screened computer monitor units